The global healthcare landscape is witnessing a paradigm shift in women’s diagnostic care. Traditionally, cervical cancer screening was confined to clinical settings via Pap smears. However, the emergence of At-Home Cervical Cancer Screening Devices—primarily centered around HPV self-sampling—is revolutionizing accessibility and patient autonomy. https://in.linkedin.com/company/data-bridge-market-research